Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024

SELL
$0.67 - $1.35 $90 - $182
-135 Reduced 0.3%
45,131 $31,000
Q3 2023

Nov 07, 2023

SELL
$1.02 - $1.23 $40,324 - $48,626
-39,534 Reduced 46.62%
45,266 $48,000
Q2 2023

Aug 07, 2023

BUY
$1.04 - $1.4 $88,192 - $118,719
84,800 New
84,800 $95,000
Q2 2022

Aug 04, 2022

SELL
$0.67 - $1.4 $34,119 - $71,295
-50,925 Reduced 98.28%
890 $1,000
Q1 2022

May 05, 2022

BUY
$1.23 - $3.31 $167 - $450
136 Added 0.26%
51,815 $64,000
Q4 2021

Feb 02, 2022

SELL
$2.89 - $4.43 $635 - $974
-220 Reduced 0.42%
51,679 $168,000
Q3 2021

Nov 02, 2021

SELL
$3.36 - $4.62 $84,594 - $116,317
-25,177 Reduced 32.67%
51,899 $216,000
Q2 2021

Aug 02, 2021

BUY
$2.82 - $5.01 $102,791 - $182,619
36,451 Added 89.73%
77,076 $322,000
Q1 2021

May 11, 2021

BUY
$2.92 - $5.07 $35,989 - $62,487
12,325 Added 43.55%
40,625 $184,000
Q4 2020

Feb 08, 2021

SELL
$1.64 - $3.42 $55,268 - $115,254
-33,700 Reduced 54.35%
28,300 $86,000
Q2 2020

Aug 07, 2020

BUY
$1.83 - $4.06 $113,460 - $251,719
62,000 New
62,000 $176,000
Q2 2019

Aug 09, 2019

SELL
$1.79 - $3.05 $9,308 - $15,859
-5,200 Closed
0 $0
Q4 2018

Feb 08, 2019

SELL
$2.66 - $15.93 $44,688 - $267,624
-16,800 Reduced 76.36%
5,200 $14,000
Q2 2018

Aug 10, 2018

BUY
$9.36 - $13.25 $76,752 - $108,650
8,200 Added 59.42%
22,000 $292,000
Q4 2017

Feb 13, 2018

BUY
$8.97 - $23.38 $11,661 - $30,394
1,300 Added 10.4%
13,800 $135,000
Q2 2017

Aug 11, 2017

BUY
N/A
12,500
12,500 $248,000

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.